DNLI

24.18

3.47% -0.87

Dopo l'orario di chiusura: 24.18

Denali Therapeutics Inc (DNLI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché DNLI Giù? Forum Previsione

Precedente Chiudi:

$25.05

Aprire:

$25.07

Volume 24 ore:

1.16M

Relative Volume:

1.39

Capitalizzazione di mercato:

$3.48B

Reddito:

$340.81M

Utile/perdita netta:

$-419.65M

Rapporto P/E:

-22.18

EPS:

-1.09

Flusso di cassa netto:

$-402.10M

1 W Prestazione:

-23.43%

1M Prestazione:

-12.36%

6M Prestazione:

+17.89%

1 anno Prestazione:

+28.89%

Intervallo 1D:

$24.06

$25.35

Intervallo di 1 settimana:

$24.06

$31.47

Portata 52W:

$14.56

$33.33

Denali Therapeutics Inc Stock (DNLI) Company Profile

Nome

Denali Therapeutics Inc

Settore

Healthcare (1196)

Industria

Biotechnology (683)

Telefono

(650) 866-8548

Indirizzo

161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO

Dipendente

390

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

DNLI's Discussions on Twitter

Confronta DNLI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DNLI	24.18	3.48B	340.81M	-419.65M	-402.10M	-1.09
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-13	Iniziato	Citigroup	Buy
2023-11-20	Ripresa	JP Morgan	Overweight
2023-10-24	Ripresa	Cantor Fitzgerald	Overweight
2023-09-06	Iniziato	B. Riley Securities	Buy
2023-01-30	Iniziato	SVB Securities	Outperform
2022-12-05	Iniziato	Cowen	Outperform
2022-11-02	Aggiornamento	BTIG Research	Neutral → Buy
2022-11-02	Iniziato	BofA Securities	Buy
2022-06-23	Iniziato	Berenberg	Buy
2021-12-10	Ripresa	Raymond James	Mkt Perform
2021-09-21	Iniziato	Oppenheimer	Outperform
2021-09-01	Iniziato	SMBC Nikko	Outperform
2021-05-18	Iniziato	UBS	Buy
2021-02-26	Reiterato	H.C. Wainwright	Buy
2021-02-10	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2020-11-11	Reiterato	H.C. Wainwright	Buy
2020-10-16	Downgrade	BTIG Research	Buy → Neutral
2020-09-14	Ripresa	JP Morgan	Overweight
2020-08-20	Reiterato	H.C. Wainwright	Buy
2020-03-13	Aggiornamento	Evercore ISI	In-line → Outperform
2020-02-28	Aggiornamento	Wedbush	Neutral → Outperform
2020-02-24	Iniziato	Jefferies	Buy
2020-02-19	Iniziato	Stifel	Hold
2020-01-27	Aggiornamento	Goldman	Neutral → Buy
2019-09-26	Iniziato	Wedbush	Neutral
2019-09-13	Iniziato	Nomura	Buy
2019-08-09	Iniziato	BTIG Research	Buy
2019-06-26	Iniziato	H.C. Wainwright	Buy
2018-11-15	Iniziato	Cantor Fitzgerald	Overweight
2018-11-12	Iniziato	Janney	Buy
2018-03-12	Downgrade	Evercore ISI	Outperform → In-line
2018-01-02	Iniziato	Evercore ISI	Outperform
2018-01-02	Iniziato	Goldman	Neutral
2018-01-02	Iniziato	JP Morgan	Overweight
2018-01-02	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Denali Therapeutics Inc Borsa (DNLI) Ultime notizie

Nov 16, 2024

Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat

Nov 16, 2024

Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha

Nov 16, 2024

Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 16, 2024

Nov 15, 2024

We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Yahoo Finance

Nov 15, 2024

State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 15, 2024

Nov 13, 2024

Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com

Nov 13, 2024

FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada

Nov 12, 2024

Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Australia

Nov 12, 2024

Denali Therapeutics executive sells shares worth $465,286 - Investing.com

Nov 12, 2024

Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 12, 2024

Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Denali Therapeutics stock soars to 52-week high of $32.17 - Investing.com India

Nov 11, 2024

Denali Therapeutics stock soars to 52-week high of $32.17 By Investing.com - Investing.com Canada

Nov 11, 2024

Learn to Evaluate (DNLI) using the Charts - Stock Traders Daily

Nov 11, 2024

Denali Therapeutics (NASDAQ:DNLI) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 11, 2024

Wellington Management Group LLP's Strategic Acquisition in Denal - GuruFocus.com

Nov 08, 2024

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - Yahoo Finance

Nov 08, 2024

HC Wainwright Issues Pessimistic Forecast for DNLI Earnings - MarketBeat

Nov 08, 2024

Nov 07, 2024

Denali Therapeutics (NASDAQ:DNLI) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nov 07, 2024

Denali Therapeutics (NASDAQ:DNLI) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 07, 2024

Nov 06, 2024

Denali Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com UK

Nov 06, 2024

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 06, 2024

Denali Therapeutics director Vicki Sato sells $83,375 in stock - Investing.com India

Nov 06, 2024

Nov 02, 2024

abrdn plc Sells 209,356 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 02, 2024

Nov 01, 2024

Denali Therapeutics (NASDAQ:DNLI) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat

Nov 01, 2024

Thinking about buying stock in QuickLogic, Ventyx Biosciences, D - GuruFocus.com

Nov 01, 2024

Oct 29, 2024